Uric Acid: A Biomarker and Pathogenic Factor of Affective Disorders and Neurodegenerative Diseases

被引:0
|
作者
Chu, Teng [1 ]
Liu, Ge [1 ]
Liu, Jing [1 ]
Wu, Yue [1 ]
Fang, Weirong [1 ]
机构
[1] China Pharmaceut Univ, Sch Basic Med Sci & Clin Pharm, State Key Lab Nat Med, Nanjing 210009, Peoples R China
基金
中国国家自然科学基金;
关键词
Uric acid; affective disorders; neurodegenerative diseases; inflammation; oxidative stress; autophagy; MAJOR DEPRESSIVE DISORDER; TERM ANTIDEPRESSANT TREATMENT; NF-KAPPA-B; OXIDATIVE STRESS; BIPOLAR DISORDER; PARKINSONS-DISEASE; COGNITIVE DYSFUNCTION; ALZHEIMERS-DISEASE; PURINE METABOLISM; MOUSE MODEL;
D O I
10.2174/0113816128333916241003180018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Uric acid (UA), the end-product of purine metabolism, has a complicated physiological role in the body, showing the combination of regulating inflammatory response, promoting oxidation/anti-oxidation, and modifying autophagy activity in vivo. Meanwhile, various research and theories support that inflammation, oxidative stress, and other risk factors promote the onset and progression of affective disorders and neurodegenerative diseases. Existing studies suggest that UA may be involved in the pathophysiological processes of affective disorders in various ways, and there has been a gradual advance in the understanding of the interplay between UA levels and affective disorders and neurodegenerative diseases. This review summarized the role of UA in the process of inflammation, oxidative stress, and autophagy. On this basis, we discussed the correlation between UA and affective disorders and several neurodegenerative diseases, and simultaneously analyzed the possible mechanism of its influence on affective disorders and neurodegenerative diseases, to provide a theoretical basis for UA as a biomarker or therapeutic target for the diagnosis of these diseases.
引用
收藏
页码:585 / 597
页数:13
相关论文
共 50 条
  • [22] MITOCHONDRIAL DISORDERS IN NEURODEGENERATIVE DISEASES
    Aydin, Makbule
    IUBMB LIFE, 2009, 61 (03) : 315 - 316
  • [23] Sleep disorders in neurodegenerative diseases
    Raggi, A.
    Ferri, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (11) : 1326 - 1338
  • [24] Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases
    Xu, Lin
    Li, Chengwei
    Wan, Tiantian
    Sun, Xinyi
    Lin, Xiaojie
    Yan, Dong
    Li, Jianjun
    Wei, Penghui
    CELL COMMUNICATION AND SIGNALING, 2025, 23 (01)
  • [25] Late-onset affective and psychotic disorders: The challenge of disentangling neurodegenerative diseases from primary psychiatric disorders
    Zorzi, Giovanni
    Busse, Cinzia
    Cecchin, Diego
    Roiter, Beatrice
    Perini, Giulia
    Cagnin, Annachiara
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 124 - 125
  • [26] The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders
    Cutler, Roy G.
    Camandola, Simonetta
    Malott, Kelli F.
    Edelhauser, Maria A.
    Mattson, Mark P.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (21) : 2233 - 2238
  • [27] Increased Serum Uric Acid as a Risk Factor for Cardiovascular Diseases
    Borghi C.
    Reggi A.
    Pavesi A.
    Cicero A.F.G.
    Current Obesity Reports, 2013, 2 (4) : 301 - 305
  • [28] Oleanolic acid and ursolic acid: therapeutic potential in neurodegenerative diseases, neuropsychiatric diseases and other brain disorders
    Chen, Chen
    Ai, Qidi
    Shi, Axi
    Wang, Nan
    Wang, Lina
    Wei, Yuhui
    NUTRITIONAL NEUROSCIENCE, 2023, 26 (05) : 414 - 428
  • [29] Uric Acid as a Biomarker for Mood Disorders: A Comparative Study of Blood Uric Acid Levels Correlating With the Symptom Severity and Treatment Response
    Immanuel, Sylviah
    Kaki, Aruna
    Jetty, Ramya Rachel
    Vupputuri, Sudha Manaswini
    Ramireddy, K., V
    Saravanan, R. Arul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [30] Pathogenic Role of Ganglioside Metabolism in Neurodegenerative Diseases
    Ariga, Toshio
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (10) : 1227 - 1242